CH404678A - Verfahren zur Herstellung von neuen 3,8-Diazabicyclo-(3,2,1)-octanen - Google Patents

Verfahren zur Herstellung von neuen 3,8-Diazabicyclo-(3,2,1)-octanen

Info

Publication number
CH404678A
CH404678A CH163161A CH163161A CH404678A CH 404678 A CH404678 A CH 404678A CH 163161 A CH163161 A CH 163161A CH 163161 A CH163161 A CH 163161A CH 404678 A CH404678 A CH 404678A
Authority
CH
Switzerland
Prior art keywords
octanes
diazabicyclo
preparation
new
Prior art date
Application number
CH163161A
Other languages
English (en)
Inventor
Cignarella Giorgio
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5642/60A external-priority patent/GB937183A/en
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of CH404678A publication Critical patent/CH404678A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH163161A 1960-02-17 1961-02-10 Verfahren zur Herstellung von neuen 3,8-Diazabicyclo-(3,2,1)-octanen CH404678A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5642/60A GB937183A (en) 1960-02-17 1960-02-17 3,8-diazabicyclo-[3,2,1]-octanes
GB2069560 1960-06-13

Publications (1)

Publication Number Publication Date
CH404678A true CH404678A (de) 1965-12-31

Family

ID=26240042

Family Applications (2)

Application Number Title Priority Date Filing Date
CH702061A CH408036A (de) 1960-02-17 1961-02-10 Verfahren zur Herstellung von 3,8-Diazabicyclo-(3,2,1)-octan-2,4-dionen
CH163161A CH404678A (de) 1960-02-17 1961-02-10 Verfahren zur Herstellung von neuen 3,8-Diazabicyclo-(3,2,1)-octanen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH702061A CH408036A (de) 1960-02-17 1961-02-10 Verfahren zur Herstellung von 3,8-Diazabicyclo-(3,2,1)-octan-2,4-dionen

Country Status (3)

Country Link
US (1) US3221015A (de)
CH (2) CH408036A (de)
DE (2) DE1200316B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222047A (en) * 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
ZA877471B (en) * 1986-10-08 1988-04-05 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds

Also Published As

Publication number Publication date
US3221015A (en) 1965-11-30
DE1445094A1 (de) 1968-11-21
CH408036A (de) 1966-02-28
DE1200316B (de) 1965-09-09

Similar Documents

Publication Publication Date Title
CH423799A (de) Verfahren zur Herstellung von 3,8-Diazabicyclo-(3,2,1)-oktanen
CH390924A (de) Verfahren zur Herstellung von 1,3,4-Thiadiazolen
CH384750A (de) Verfahren zur Herstellung von neuen 2,3 : 6,7-Diareno-1-oxa-4,5-diazepinen
AT253493B (de) Verfahren zur Herstellung von neuen 4-Alkyl-3, 3-disubstituierten-1-substituierten-pyrrolidin-2-onen und -pyrrolidin-2-thionen
CH405326A (de) Verfahren zur Herstellung von 1,3-Diaryl-pyrazolinen
CH412900A (de) Verfahren zur Herstellung von neuen Benzo-1,3-oxazin-dionen-(2,4)
AT246157B (de) Verfahren zur Herstellung von neuen Benzazocinverbindungen
CH398622A (de) Verfahren zur Herstellung von 2,4-Bis-amino-6-trichlormethyl-s-triazinen
AT227693B (de) Verfahren zur Herstellung von neuen, 1-substituierten 2-(α-Oxo-aralkyl)-benzimidazolen
AT240863B (de) Verfahren zur Herstellung von neuen 2-Acyl-hydrazino-4,6-bis-tert.-amino-1,3,5-triazinen
CH381242A (de) Verfahren zur Herstellung von neuen substituierten 2,3-Diphenyl-propylaminen
CH424758A (de) Verfahren zur Herstellung von 2,6-Dichlorbenzaldoxim
CH408036A (de) Verfahren zur Herstellung von 3,8-Diazabicyclo-(3,2,1)-octan-2,4-dionen
CH388969A (de) Verfahren zur Herstellung von 4,4'-Methenyl-bis-(pyrazolonen-(5))
AT252237B (de) Verfahren zur Herstellung von neuen 2-Isoxazolin-5-onen
CH380143A (de) Verfahren zur Herstellung von neuen 4-substituierten 1,2-Diaryl-3,5-dioxo-pyrazolidinen
CH381695A (de) Verfahren zur Herstellung von neuen 4-substituierten 1,2-Diaryl-3,5-dioxo-pyrazolidinen
CH393340A (de) Verfahren zur Herstellung von neuen 4-Hydrazino-2H-1,2,3-benzothiadiazin-1,1-dioxyden
AT232515B (de) Verfahren zur Herstellung von neuen 3, 8-Diazabicyclo-(3, 2, 1)-oktanen
CH375364A (de) Verfahren zur Herstellung von neuen, basisch substituierten 6-Methyl-ergolen(9)-Derivaten
CH428763A (de) Verfahren zur Herstellung von Enhalogeniden von Grisantrion-(3,2',4')
CH400170A (de) Verfahren zur Herstellung von 3,5-Pyrazolidindionderivaten
AT233141B (de) Verfahren zur Herstellung von neuen Tetrazapolymethinfarbstoffen
AT231988B (de) Verfahren zur Herstellung von neuen 4-substituierten 1, 2-Diaryl-3, 5-dioxo-pyrazolidinen
AT231989B (de) Verfahren zur Herstellung von neuen 4-substituierten 1, 2-Diaryl-3, 5-dioxo-pyrazolidinen